GRIFOLS | GRF - Operating Profit


GRIFOLS reported EUR394M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
Alcon AG USD 44M 253M Jun/2026
Almirall EUR 71.55M 41.32M Jun/2026
Amadeus IT EUR 527.1M 48.8M Sep/2026
Amarin USD -2.26M 564K Dec/2025
argenx SE USD 486M 7M Sep/2026
AstraZeneca USD 4.66B 1.5B Sep/2026
Bayer EUR 129M 698M Sep/2026
Cie Automotive EUR 264.84M 21.12M Dec/2025
Demant DKK 2.12B 35M Jun/2026
Ence Energia y Celulosa EUR -6.62M 28.28M Sep/2026
Essilor EUR 2.3B 919M Jun/2026
Ferrovial EUR 294M 293M Jun/2026
Fresenius EUR 639M 80M Sep/2026
Fresenius Medical Care EUR 384M 153.27M Sep/2026
Genmab DKK 407M 182M Jun/2026
GlaxoSmithKline GBP 2.86B 251M Sep/2026
GRIFOLS EUR 394M 65M Sep/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Inditex EUR 9.84B 8.08B Jun/2026
Lakefront Biotherapeutics EUR -43.51M 20.19M Jun/2026
Merck EUR 1.1B 51M Jun/2026
Novartis USD 5.14B 392M Sep/2026
Philips EUR 165M 445M Sep/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sanofi EUR 4.72B 2.34B Sep/2026
Smith & Nephew USD 505M 65M Jun/2026
UCB EUR 1.29B 571M Dec/2025
Viscofan EUR 51.42M 1.87M Sep/2026